Home AstraZeneca

AstraZeneca

In operation
-
Cancer Drug Developer

Basic Information

Astrazeneca Investment (China) Co., Ltd. is a subsidiary of AstraZeneca.AstraZeneca is one of the world's leading pharmaceutical companies, headquartered in London, UK, with its R&D headquarters located in Sweden. The company operates 11 R&D centers and 31 production bases worldwide, and its products are sold in over 100 countries and regions. AstraZeneca holds a leading position in cardiovascular, gastrointestinal, respiratory, anesthesia, oncology, and central nervous system fields.AstraZeneca China Innovation Center is located in Zhangjiang, Shanghai. It is the latest cancer drug R&D center established by AstraZeneca in China, dedicated to seeking innovative ideas, developing safe and effective cancer drugs, exploring life-saving methods, and bringing them to a wide range of patients across Asia.
Astrazeneca Investment (China) Co., Ltd.
Shanghai,China
more than 500 people
September 20, 2007
zhijie.fan@astrazeneca.com